Local Pharmacovigilance Support in Puerto Rico
Pharmacovigilance enables firms in the field of life sciences to systematically look at the safety of pharmaceutical products, discover emerging risks and take appropriate regulatory actions. DDReg's Pharmacovigilance Services in Puerto Rico assist pharmaceutical, biotechnology and life sciences firms with the management of safety information, reporting of adverse events and monitoring of literature, detection of signals as well as aggregate reporting and Pharmacovigilance compliance. In its role as a partner in the industry in the field of Pharmacovigilance (PV), DDReg offers Puerto Rico Pharmacovigilance Services as part of a bigger safety strategy or to assist with specific PV activities.
Pharmaceutical Regulatory Framework in Puerto Rico
The pharmacovigilance framework in Puerto Rico for pharmaceutical products that are FDA-regulated is primarily linked with the U.S. federal regulatory framework. All relevant pharmaceutical and biological products are subject to FDA postmarketing requirements for safety reports set out in CFR 314.80 and 600.80. Responsible parties must examine relevant adverse event data prior to reporting any relevant safety incidents according to the relevant FDA regulations.
In postmarketing cases that involve serious and unexpected adverse events, FDA requires 15-day Alert reports to be filed as soon as possible and no later than 15 calendar days from the initial receipt of the report by the responsible person.
Puerto Rico also maintains territory-specific regulations for pharmaceuticals. The Department's Division of Medicines and Pharmacies is responsible for regulating these In postmarketing cases that involve severe and unexpected adverse events, FDA requires 15-day Alert reports to be filed as soon as is possible and not more by 15 calendar day from the initial receipt of the report by the responsible person. as well as issuing licenses to businesses engaged in manufacturing, distributing, storing, dispensing, and selling medicines, and also registering drugs and taking measures to regulate them.
Businesses that operate in Puerto Rico should assess relevant FDA prescriptions for pharmacovigilance and Puerto Rico-specific pharmaceutical regulations related with their products, establishments, or activities.
Our Pharmacovigilance Services in Puerto Rico
DDReg provides focused Pharmacovigilance Consulting in Puerto Rico to help organizations establish, manage, and strengthen their safety processes.
- ICSR Management: Support for adverse-event intake, case processing, assessment, coding, follow-up, quality review, and case closure.
- Adverse Event Reporting: Support for identifying reportable cases, preparing safety reports, and managing applicable regulatory reporting timelines.
- Literature Surveillance: Monitoring relevant scientific and medical literature to identify potential safety information and reportable cases.
- Signal Detection & Management: Identification, assessment, documentation, and ongoing monitoring of potential safety signals.
- Aggregate Safety Reporting: Support for applicable periodic and aggregate safety reports, including safety-data review, analysis, and report preparation.
- PV Quality & Compliance: Support for PV gap assessments, SOP development and review, training, CAPA, quality reviews, audit preparation, and inspection readiness.
Drug Safety Support Throughout the Product Lifecycle
DDReg provides Drug Safety Services in Puerto Rico across the product lifecycle, helping organizations maintain appropriate safety oversight as new information becomes available.
Our support can be integrated into an existing global pharmacovigilance system or provided as PV Outsourcing Services in Puerto Rico for selected activities or ongoing operations. The specific safety-reporting requirements may vary according to the product, regulatory status, application type, and applicable FDA requirements. For example, FDA's postmarketing reporting framework contains specific provisions for drugs, biologics, and certain combination products.
Why Choose DDReg as Your Pharmacovigilance Service Partner
DDReg combines pharmacovigilance expertise with regulatory knowledge to support companies operating in Puerto Rico and other global markets.
Our capabilities include:
- 17+ years of global pharmacovigilance expertise
- End-to-End Pharmacovigilance Support
- ICSR Processing & Case Management
- Adverse Event Reporting
- Literature Monitoring
- Signal Detection & Safety Surveillance
- Aggregate Reporting Support
- PV Quality & Compliance
- Audit & Inspection Readiness
- Project-Based or Ongoing PV Support
For companies seeking pharmacovigilance support in Puerto Rico, DDReg can provide dedicated regulatory and safety support for activities associated with the Puerto Rico market while coordinating with broader global PV operations.
Global Reach Explorer
Find Your Solution
Our Pharmacovigilance (PV) Services Expertise
ICSR Case Processing and Submission
Our advanced Individual Case Safety Report (ICSR) Pharmacovigilance Services are dedicated to ensuring patient safety through precise case handling....
Literature Monitoring
DDReg’s Literature Monitoring Services offer advanced pharmacovigilance literature screening for drug safety. We help Marketing...
Risk Management
Our expert risk management solutions ensure patient safety by proactively addressing potential hazards in pharmaceutical...
Audit and Compliance
Our specialized services ensure that pharmacovigilance systems across the drug development pipeline meet strict regulatory...
Pharmacovigilance Signal Management Services
DDReg’s specialized pharmacovigilance services ensure that potential adverse events are identified and addressed promptly...
QPPV Services
DDReg’s expert team provides comprehensive QPPV services designed to strengthen your pharmacovigilance system. We ensure that...
